1-4 of 4
Karin Vargova, Msc.
Close
Sort by
Journal Articles

PU.1 and p53 Double Mutant Mice Develop Aggressive AML with Dysplastic Features

Petra Vlckova, MSc., Libor Stanek, MSc., Pavel Burda, PhD, Karin Vargova, MSc., Filipp Savvulidi, Martina Kapalova, MSc., Ulrich Steidl, MD, PhD, Tomas Stopka, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 769.
https://doi.org/10.1182/blood.V120.21.769.769
Published: 2012
Journal Articles

Transcription Factor CTCF Inhibits Effects of 5-Azacitidine in MDS/AML Cells

Martina Kapalova, MSc., Pavel Burda, PhD, Karin Vargova, MSc., Filipp Savvulidi, Tomas Zikmund, MSc., Nikola Curik, PhD, Anna Jonasova, Tomas Stopka, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3848.
https://doi.org/10.1182/blood.V120.21.3848.3848
Published: 2012
Journal Articles

Mutual Regulatory Loop between miR-155 and PU.1 Is a Candidate Pathogenesis Factor in CLL.

Tomas Stopka, MD, PhD, Karin Vargova, Msc., Juraj Kokavec, Msc., Vit Pospisil, Msc., Nikola Curik, Msc., Pavel Burda, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD.
Journal: Blood
Blood (2007) 110 (11): 1130.
https://doi.org/10.1182/blood.V110.11.1130.1130
Published: 2007
Journal Articles

ISWI ATPase Snf2h Is Required for Both Heterochromatin and Euchromatin Structure in ES Cells.

Jarmila Podskocova, Msc., Karin Vargova, Msc., Juraj Kokavec, Msc., Arthur I. Skoultchi, PhD., Tomas Stopka, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4062.
https://doi.org/10.1182/blood.V110.11.4062.4062
Published: 2007